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Collateral gradeAbstract Objectives: To assess the impact of angina prior to ﬁrst attack of acute anterior wall
ST-segment elevation myocardial infarction (STEMI) on immediate angiographic and echocardio-
graphic outcomes after primary percutaneous coronary intervention (PPCI).
Methods: A total of 100 patients with acute anterior wall STEMI managed by PPCI were included
(50 patients with pre-infarction angina (PIA) and 50 patients without). Patients were observed for
angiographic outcome (coronary collateral grade, ﬁnal TIMI and TMP ﬂow grade) and echocardio-
graphic outcome.
Results: Baseline patient characteristics were similar in both groups. PIA group had more patients
with grade 3 coronary collaterals (p= 0.006), more patients with TIMI 3 ﬂow grade after PPCI
(p= 0.0002), less patients with TMP 0 ﬂow grade (p= 0.013). The group with no PIA had more
advanced Killip class at presentation (p= 0.015).
No difference was present between both groups regarding post-PPCI LV ejection fraction
(p= 0.255), LV end diastolic dimensions (p= 0.553), LV end systolic dimensions (p= 0.908), seg-
mental wall motion score index (p= 0.214).
Conclusions: For patients suffering from a ﬁrst attack of acute anterior wall STEMI, pre-infarction
angina is associated with a better Killip class at presentation, better TIMI ﬂow grade after PPCI,
less incidence of TMP 0 ﬂow grade.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Patients who suffer acute myocardial infarction (AMI)
frequently experience prodromal symptoms preceding the
attack itself known as pre-infarction angina (PIA). The clinical
signiﬁcance of PIA remains controversial. Studies have
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size and better in-hospital outcome after AMI. This protective
effect has been attributed to ischemic preconditioning, earlier
reperfusion or better collateral circulation development.1,2
Preconditioning is the process by which brief, repetitive epi-
sodes of ischemia reduce the size of a subsequent myocardial
infarction.3 Several experimental and clinical studies reported
improved outcome in AMI patients who experience pre-
infarction angina who appeared to have decreased mortality,
pump failure, arrhythmias, and peak cardiac serum enzyme
levels as well as enhanced recovery of cardiac contractile func-
tion.4–7
Studies have shown that PIA was associated with better
5-year clinical outcomes in STEMI patients undergoing
primary PCI.8
The aim of this study was to assess the impact of pre-
infarction angina prior to ﬁrst attack of acute anterior wall
ST-segment elevation myocardial infarction (STEMI) on
angiographic and echocardiographic outcomes after primary
percutaneous coronary intervention (PPCI).2. Materials and methods
2.1. Study design
We conducted a prospective study of 100 patients presenting
with ﬁrst attack of acute anterior wall STEMI who were man-
aged by PPCI.
MI was deﬁned using the third universal deﬁnition of MI
as the detection of a rise and/or fall of cardiac biomarkers,
with at least one of the values being elevated (>99th per-
centile upper reference limit) (using cardiac Troponin in this
study), in addition to one of the ﬁve following predeﬁned
criteria: (1) symptoms of myocardial ischemia; (2) new (or
presumably new) signiﬁcant ST-segment/T-wave changes or
left bundle branch block; (3) development of pathological
Q waves on ECG; (4) new loss of viable myocardium or
regional wall motion abnormality by imaging; and (5) iden-
tiﬁcation of intracoronary thrombus by angiography or
autopsy.9
Patients were excluded from the study for any of the follow-
ing reasons: presenting more than 24 h after onset of chest
pain, receiving ﬁbrinolytic therapy, history of previous MI or
acute coronary syndrome, history of chronic stable angina,
STEMI in a territory other than the anterior wall, undergoing
PPCI without stenting, chronic kidney disease requiring regu-
lar dialysis.
2.2. Patient groups
We assigned patients into two groups according to the pres-
ence or absence of pre-infarction angina (PIA) deﬁned as the
occurrence of attacks of typical transient ischemic-type chest
pain (lasting less than 30 min) within the 24 h prior to develop-
ing MI; we enrolled 50 consecutive patients in each group.
Approval of institutional ethical committee was obtained as
well as an informed consent from each patient.
All patients received aspirin (300 mg PO) and clopidogrel
(600 mg PO) in the emergency room. A detailed history and
clinical examination were performed with particularassessment of occurrence of PIA, presence of cardiac risk fac-
tors including smoking (current, regular use of any amount of
tobacco or stopped less than 6 months ago), presence of hyper-
tension (receiving hypertension treatment or blood
pressure > 140/90 mmHg), diabetes mellitus (receiving treat-
ment for hyperglycemia), family history of premature
atherosclerotic coronary artery disease (ﬁrst degree relative
with diagnosed CAD< 60 years old). Also, Pain-to-door time
was assessed as the time from onset of persistent chest pain to
ﬁrst medical contact.
2.3. Angiographic measurements
Coronary angiography was performed from the right femoral
artery access site. Right coronary angiography was done ﬁrst
using a diagnostic catheter after which left coronary angiogra-
phy in multiple orthogonal views was done using a guiding
catheter. Patients underwent PPCI according to the current
standards with stenting to the left anterior descending (LAD)
artery using bare metal stents (BMS). Thrombus aspiration
was not performed in any of the patients. A single run of bal-
loon angioplasty was allowed using an undersized balloon
(maximum 2.0 mm in diameter) inﬂated at nominal pressure
after which stenting was performed. Glycoprotein IIb/IIIa
antagonists were not administered during or after the
procedure.
Coronary collateral grade to the LAD was assessed prior to
PPCI. Both ﬁnal Thrombolysis In Myocardial Infarction
(TIMI) ﬂow grade and Thrombolysis in Myocardial
Infarction myocardial perfusion (TMP) grade were assessed
after PPCI was done.
Final TIMI ﬂow grade was classiﬁed as TIMI 3 for normal
antegrade ﬂow and contrast clearance from the epicardial
artery beyond the (stented) obstruction (complete perfusion);
TIMI 2 for full opaciﬁcation of the distal artery, but with
slower contrast ﬂow or clearance, or both, beyond the
(stented) obstruction compared with a non-culprit artery or
the culprit artery proximal to the lesion (partial reperfusion);
TIMI 1 for contrast ﬂow in part, but not all, of the artery distal
to the (stented) obstruction (penetration without perfusion);
TIMI 0 for no antegrade contrast ﬂow beyond the point of
occlusion (no perfusion).10
Final TMP grade was classiﬁed as TMP grade 3 when there
was the normal diffuse ground glass appearance of myocardial
blush so that at the end of the washout phase, dye was only
mildly persistent or gone; TMP grade 2 when dye entered
the myocardium, but accumulated and exited more slowly,
so that at the end of the washout phase dye in the myocardium
was strongly persistent; however, dye totally cleared by the
next injection; TMP grade 1 when the dye did not leave the
myocardium and there was a stain on the next injection;
TMP grade 0 when dye did not enter the myocardium and
there was minimal or no blush apparent during the injection
and washout phases.11
Grades of coronary collaterals were classiﬁed according to
Rentrop as Grade 0 for no collaterals; Grade 1 for ﬁlling of side
branches of the artery to be perfused via collateral vessels with-
out visualization of the epicardial segment; Grade 2 for partial
ﬁlling of the epicardial segment via collateral vessels; Grade 3
for complete ﬁlling of the epicardial segment via collateral
vessels.12
Table 1 Baseline characteristics.
Clinical characteristic PIA group
n= 50
No PIA group
n= 50
p-value
Age, years 56.5 ± 12.2 55.9 ± 10.5 0.839
Male gender 46 (92%) 40 (80%) 0.148
Smoking 36 (72%) 31 (62%) 0.395
Hypertension 13 (26%) 13 (26%) 1.18
Diabetes mellitus 16 (32%) 15 (30%) 1
Positive FH of CAD 3 (6%) 3 (6%) 1.322
Killip class
1 46 (92%) 35 (70%) 0.009
2 2 (4%) 3 (6%) 1
3 0 (0%) 1 (2%) 1
4 2 (4%) 11 (22%) 0.015
Pain-to-door time
(hours)
5.7 ± 4.4 7.5 ± 7 0.232
Continuous variables are expressed as mean and standard devia-
tion; whereas categorical variables are expressed as numbers
(percentage).
FH of CAD indicates family history of premature atherosclerotic
coronary artery disease; PIA indicates pre-infarction angina.
Table 2 Baseline coronary collateral grade before PPCI and
immediate angiographic outcome.
Angiographic ﬁnding PIA group
n= 50
No PIA group
n= 50
p-value
Coronary collateral grade
Rentrop grade 0 22 (44%) 39 (78%) 0.0009
Rentrop grade 1 13 (26%) 6 (12%) 0.125
Rentrop grade 2 7 (14%) 5 (10%) 0.759
Rentrop grade 3 8 (16%) 0 (0%) 0.006
Final TIMI ﬂow grade
TIMI 0 0 (0%) 2 (4%) 0.495
TIMI 1 0 (0%) 7 (14%) 0.013
TIMI 2 2 (4%) 8 (16%) 0.091
TIMI 3 48 (96%) 33 (66%) 0.0002
Final TMP grade
TMP 0 0 (0%) 7 (14%) 0.013
TMP 1 3 (6%) 2 (4%) 1
TMP 2 9 (18%) 11 (22%) 0.803
TMP 3 38 (76%) 30 (60%) 0.133
Categorical variables are expressed numbers (percentage).
PIA indicates pre-infarction angina; TIMI indicates Thrombolysis
In Myocardial Infarction; TMP indicates Thrombolysis In
Myocardial Infarction myocardial perfusion.
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A full trans-thoracic echocardiography study was performed
for all patients on the morning after PPCI using a General
Electric S5 echocardiography machine with a 2.5 MHz phased
array transducer with the patient lying in the left lateral decu-
bitus position. All examinations were done by an experienced
echocardiographer who was blinded to the patients’ group.
The following measurements were obtained: Left ventricu-
lar (LV) dimensions, left ventricular ejection fraction (LVEF)
assessed using the modiﬁed Simpson method of discs, mitral
regurgitation grade, and the segmental wall motion score index
according to the 16-segment model described by the American
Society of Echocardiography.13
2.5. Comparing outcome
Both groups were compared regarding:
A. Angiographic outcome after revascularization: (1) Final
TIMI ﬂow grade in the LAD. (2) Final TMP grade in
the LAD territory.
B. Echocardiographic outcome: LV dimensions, LVEF
assessed by the modiﬁed Simpson method of discs and
segmental wall motion score index.
2.6. Statistical analysis
Data were coded, tabulated, and statistically analyzed using
Graph Pad Prism software. Descriptive statistics were done
for continuous variables as mean ± standard deviation, while
they were done for categorical variables as number and per-
centage. Tests performed were 2-tailed Student t-test and
Fisher’s exact test. The level of signiﬁcance was taken at p
value less than 0.05, otherwise was considered non-signiﬁcant.
3. Results
Our study included 100 patients (from April 2013 to March
2014) classiﬁed into two equal groups: PIA group represents
patients with history of pre-infarction angina (n= 50) and
no-PIA group represents patients without history of pre-
infarction angina (n= 50). All patients survived the PPCI pro-
cedure, 2 (2%) died in-hospital and the remaining 98 (98%)
were healthily discharged from the hospital.
3.1. Baseline clinical characteristics
The 2 study groups were balanced as regards age, gender and
cardiac risk factors (smoking, presence of hypertension, dia-
betes mellitus (type 2 in all), family history of premature
atherosclerotic coronary artery disease). Pain-to-door time
(from onset of persistent chest pain to ﬁrst medical contact)
was slightly shorter in the PIA group but not statistically sig-
niﬁcant (Table 1).
Regarding Killip class at presentation, more patients of the
PIA group were in class 1 (92% vs. 70%, p= 0.009), while
more of the no-PIA group were in class 4 (24% vs. 4%,
p= 0.015) (Table 1).3.2. Baseline coronary collateral grade prior to PPCI
The coronary collaterals grade of the whole cohort was:
Rentrop grade 0 collaterals in 61 patients (61%), Rentrop
grade 1 collaterals in 19 patients (19%), Rentrop grade 2 col-
laterals in 12 patients (12%) and Rentrop grade 3 collaterals in
8 patients (8%).
There were more patients with coronary grade 3 collaterals
in the PIA group (16% vs. 0%, p= 0.006) and less with coro-
nary grade 0 collaterals (44% vs. 78%, p= 0.0009) (Table 2).
Table 3 Echocardiographic outcome.
Outcome PIA group
n= 50
No PIA group
n= 50
p-value
General echocardiographic outcome
LVEDD (mm) 53.4 ± 7.6 54.2 ± 5.7 0.553
LVESD (mm) 39.4 ± 9.4 39.6 ± 7.8 0.908
LVEF (%) 39.9 ± 10.4 42.4 ± 11.4 0.255
RSWMA score
index
1.8 ± 0.4 1.7 ± 0.4 0.214
Grade of mitral regurgitation (MR)
No MR 25 (50%) 20(40%) 0.422
1/4 MR 23 (46%) 25 (50%) 0.842
2/4 MR 2 (4%) 3 (6%) 1
3/4 MR 0 (0%) 2 (4%) 0.495
4/4 MR 0 (0%) 0 (0%) –
Continuous variables are expressed as mean and standard devia-
tion; whereas categorical variables are expressed numbers
(percentage).
LVEDD indicates left ventricular end diastolic dimension; LVEF
indicates left ventricular ejection fraction; LVESD indicates left
ventricular end systolic dimension; PIA indicates pre-infarction
angina; RSWMA indicates resting segmental wall motion
abnormality.
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The ﬁnal TIMI ﬂow grade of the whole cohort was TIMI 0 in 2
patients (2%), TIMI 1 in 7 patients (7%), TIMI 2 in 10
patients (10%) and TIMI 3 in 81 patients (81%). There were
more patients with TIMI ﬂow 3 in the PIA group (96% vs.
66%, p= 0.0002) and more with TIMI ﬂow 1 in the no-PIA
group (14% vs. 0%, p= 0.013) (Table 2).
The ﬁnal TMP grade of the whole cohort was TMP 0 in 7
patients (7%), TMP 1 in 5 patients (5%), TMP 2 in 20 patients
(20%) and TMP 3 in 68 patients (68%). There were more
patients with TMP grade 0 in the no-PIA group (7% vs.
0%, p= 0.013) (Table 2).
3.4. Echocardiographic outcome
There were no signiﬁcant differences between the two groups
regarding echocardiographic measurements of LV dimensions,
LVEF, resting segmental wall abnormality index and grade of
mitral regurgitation (Table 3).
4. Discussion
This study provides further evidence that pre-infarction angina
(PIA) is associated with better angiographic outcome in
patients presenting with acute STEMI managed by PPCI and
that these patients are generally more clinically stable at pre-
sentation as demonstrated by a lower Killip class compared
to those not having PIA.
PIA has been shown in several studies to be associated with
better long-term (5 year) clinical outcome,8 and signiﬁcant
myocardial protection in the setting of PPCI with stenting dur-
ing STEMI.14 Similar ﬁndings have also been demonstrated in
patients presenting with non-STEMI, showing that PIA is very
frequent in such patients, and is associated with a betterprognosis, including reduced infarct size and in-hospital ven-
tricular arrhythmias.15
Several mechanisms may explain the differences between
infarctions preceded by PIA and those that are not such as
opening of pre-existing coronary collaterals, accelerated reper-
fusion rate, reduced microvascular obstruction and ischemic
preconditioning. Collaterals alone do not seem to explain the
beneﬁcial effects of pre-infarction angina, although it is difﬁ-
cult to completely rule out their role in the clinical setting.
The possibility that PIA is not protective per se, but rather is
a predictor of more rapid coronary reperfusion is still valid.
It is likely that the beneﬁcial effects of PIA are related to
ischemic preconditioning as both have very similar clinical fea-
tures, although a direct demonstration of this hypothesis is still
lacking.8,16
The effect of total ischemic time and time to ﬁrst medical
contact was discussed in several studies. Luz et al. performed
retrospective analyses of 575 consecutive PPCI-treated patients
where they divided the patients into three groups from symp-
tom onset to reperfusion: less than 3, 3–6, and greater than
6 h. They concluded that PPCI-treated patients within 3–6 h
from symptom onset had smaller infarcts if they had experi-
enced PIA, with no beneﬁt for those who presented less than
3 h or greater than 6 h from symptom onset.17 However, other
studies showed that the beneﬁts of PIA were mainly associated
with patients who had intermediate or late reperfusion.
Although myocardial damage increased with ischemic duration
in patients without PIA, no such correlation was observed in
those patients with PIA. Whereas infarct size was smaller in
patients with PIA regardless of ischemic time, the differences
were most pronounced in prolonged ischemic time, suggesting
that the protective effect of PIA may last for at least 6 h. This
also implies that the beneﬁt of late PCI may be greater in
patients with PIA because more myocardium can be salvaged.14
In the current study, time to ﬁrst medical contact was slightly
shorter in the PIA group but this did not reach statistical signif-
icance and effects on long-term outcomes were not investigated.
Reiter et al. performed a retrospective analysis of 1031
patients admitted with a ﬁrst STEMI who were managed by
PPCI. They concluded that the occurrence of pre-infarction
angina is associated with signiﬁcant myocardial protection.
Patients with PIA had a 50% reduction in infarct size com-
pared with those patients without PIA by peak creatine kinase
despite having identical ischemic times and angiographic area
at risk. Protective effect of pre-infarction angina was present
regardless of infarct size. In patients without PIA, they
observed a linear increase in infarct size with increasing
ischemic time. In contrast, patients with pre-infarction angina
demonstrated no correlation between ischemic time and peak
CK within 6 h of ischemia. It is noteworthy that in their study
they excluded all patients with visible collaterals to the infarct
artery, which further implies that the protective effect of PIA is
due to ‘‘preconditioning effect’’ rather than the presence of
collaterals.14
Another study by Zhang et al. examined the impact of ang-
ina prior to STEMI on short-term clinical outcomes in patients
with acute STEMI who underwent PPCI. They enrolled a total
of 875 consecutive patients with STEMI who presented within
12 h of symptom onset and who underwent sirolimus-eluting
stent-based PPCI. Of these patients, 292 (33.4%) had PIA.
The rate of MACE at 30 days was signiﬁcantly lower for
patients with PIA (7.2% vs. 12.7% in the non-PIA group,
Impact of pre-infarction angina on different outcomes 145p= 0.01). Speciﬁcally they demonstrated that in patients with
anterior MI, the rate of major adverse cardiovascular events
(MACE) at 30-day follow-up was reduced for those who had
PIA.18
Kosuge et al. presented data from the Japan Acute
Coronary Syndrome Study on 913 patients with STEMI under-
going PPCI, pre-infarction angina was observed in 39%.
Patients with pre-infarction angina and anterior STEMI had
signiﬁcant reductions in infarct size and improved mortality
compared with those without pre-infarction angina.19,20
The beneﬁt of ischemic preconditioning evoked by PIA was
also conﬁrmed using cardiac magnetic resonance (CMR) by
Lønborg et al. in their study of 200 STEMI patients. They
measured myocardial area at risk within 1–7 days and ﬁnal
infarct size 90 ± 21 days after the STEMI. Myocardial
salvage index (MSI) was calculated. Patients with PIA had a
better MSI vs. those without PIA. They concluded that
pre-infarction angina increases MSI in patients with STEMI
supporting the theory that pre-infarction angina leads to
ischemic preconditioning.21
However, other studies observed no clinical beneﬁt of pre-
infarction angina. Zahn et al. analyzed 774 patients STEMI
from the German Myocardial Infarction Registry treated with
PPCI without stenting who had ischemic durations of up to
12 h. Pre-infarction angina occurred in 69% of all patients.
They observed no clinical beneﬁt of pre-infarction angina
regarding mortality or development of heart failure.22
De Luca et al. demonstrated that pre-infarction angina did
not affect infarct size among STEMI patients undergoing
PPCI (n= 430). Infarct size was evaluated at 30 days after
intervention by Tc99m sestamibi. Pre-infarction angina did
not affect either the rate of post-procedural TIMI 3 ﬂow or
infarct size. Similar results were observed in sub-analyses
according to infarct location, gender or ischemia time.23
It is worth mentioning that a study performed by Lorgis
et al. on 1541 patients with non-STEMI comparing patients
who had PIA (deﬁned as chest pain up to 7 days before the epi-
sode leading to admission) compared with patients without
PIA found that 45% had PIA. PIA was associated with a
lower creatine kinase peak, as a reﬂection of infarct size.
Patients with PIA developed fewer ventricular arrhythmias
and heart failure during the hospital stay. Overall, there was
a decrease in early cardiovascular events by 26% in patients
with PIA. They concluded that PIA is very frequent in patients
admitted for a ﬁrst non STEMI, and is associated with a better
prognosis. Accordingly they stated that protecting the myocar-
dium by ischemic or pharmacological conditioning should not
be only in STEMI, but in all types of MI.15
The variable results from such studies might be attributed
to differences in the baseline clinical characteristics of the stud-
ied populations, differences in the deﬁnition of pre-infarction
angina, difference in the time of presentation after the onset
of chest pain, variation in the method of quantiﬁcation of
infarct size and the time of follow-up, as well as differences
in pharmacological interventions among the various studies.
4.1. Study limitations
This study is a single center study with a limited number of
patients. Moreover, long term clinical and echocardiographic
follow-up were not performed.5. Conclusions
In patients presenting with ﬁrst attack of acute anterior wall
STEMI managed by PPCI, the occurrence of pre-infarction
angina was associated with better Killip class at presentation,
better coronary collateral grade at baseline, as well as, better
immediate post-procedural TIMI ﬂow grade.
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